Structure of Ferrostatin-1
CAS No.: 347174-05-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Ferrostatin-1 is a ferroptosis inhibitor with an IC50 value of 60 nM. Ferrostatin-1 has neuroprotective and antitumor effects and can be used in research on the role of ferroptosis in neurodegenerative diseases and cancer.
Synonyms: Fer-1
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 347174-05-4 |
Formula : | C15H22N2O2 |
M.W : | 262.34 |
SMILES Code : | O=C(OCC)C1=CC=C(NC2CCCCC2)C(N)=C1 |
Synonyms : |
Fer-1
|
MDL No. : | MFCD08072959 |
InChI Key : | UJHBVMHOBZBWMX-UHFFFAOYSA-N |
Pubchem ID : | 4068248 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
mouse primary microglial cells (mPMs) | 10 μM | 1 h | Inhibited HIV-1 Tat-mediated microglial ferroptosis, reduced lipid peroxidation and the release of proinflammatory cytokines. | PMC10106521 |
H9C2 cells | 2 μM | reduced DOX-induced cell death by approximately 50% | PMC10400469 | |
H9C2 cells | 2 μM | fully rescued erastin-induced cell death | PMC10400469 | |
FHs74Int cells | 5 μM | 120 h | Fer-1 significantly reduced IR-induced cell death and lipid peroxidation levels in the presence of AA | PMC10466894 |
FHs74Int cells | 5 μM | 72 h | Fer-1 significantly reduced IR-induced lipid peroxidation levels in the presence of AA | PMC10466894 |
primary cultured adult mouse cardiomyocytes (PAMCs) | 2 μM | 48 h | To explore whether E-Exe preconditioning of PAMCs could resist DIC injury-induced ferroptosis, results showed that Fer-1 significantly alleviated DIC injury | PMC10878110 |
HTR-8/SVneo cells | 5 μM | 36 h | Blocking ferroptosis significantly reversed the shFTL-induced decrease in cell viability and improved the changes in most ferroptotic marker concentrations/activities. | PMC9706170 |
L02 cells | 5 μM | 1 h | Fer-1 pretreatment significantly increased the protein expression of GPX4 and Ferritin, restored the decreased GSH levels and elevated MDA content caused by EC treatment, and alleviated the cytotoxicity induced by EC. | PMC9142717 |
RD cells | 100 μM | 36 h | Inhibited lipid peroxidation and cell death induced by CV-A6 infection | PMC8764547 |
HUVECs | 1 μM | 24 h | Inhibited ZnONPs-induced cell death and lipid peroxidation | PMC8726675 |
EA.hy926 cells | 1 μM | 24 h | Inhibited ZnONPs-induced cell death and lipid peroxidation | PMC8726675 |
LLC-MK2 cells | 40 μM | 2-5 days | Inhibited lipid peroxidation induced by CoV-229E infection | PMC8764547 |
NRK49F cells | 5 μM | 1 h | Restored GPX4 protein expression | PMC9894909 |
HK-2 cells | 5 μM | 1 h | Restored GPX4 protein expression | PMC9894909 |
ZR-75-1 | 10 µM | 1 h | Fer-1 significantly attenuated IR-induced cell death in ER-positive ZR-75-1 cells | PMC8888677 |
oligodendrocytes (OLs) | 100 nM | Protected oligodendrocytes from cystine deprivation-induced death | PMC3985476 | |
HT-1080 fibrosarcoma cells | 1 μM | 7.5 h | Inhibited erastin-induced lipid peroxidation and cell death | PMC3985476 |
human monocyte-derived macrophages | 10 µM | 4 days | inhibited Mtb-induced macrophage necrosis and lipid peroxidation | PMC6400546 |
VSC4.1 cell line | 1 μM | 12 h | To evaluate the protective effect of Ferrostatin-1 on RSL3-induced cell death, it was found that Ferrostatin-1 significantly increased cell viability | PMC11103787 |
HT22 cell line | 1 μM | 12 h | To evaluate the protective effect of Ferrostatin-1 on RSL3-induced cell death, it was found that Ferrostatin-1 significantly increased cell viability | PMC11103787 |
Huc-MSCs | 1 μM | 24 h | To evaluate the effect of Ferrostatin-1 on RSL3-induced intracellular GSH levels, it was found that Ferrostatin-1 significantly increased GSH levels | PMC11103787 |
NRK49F cells | 1 μM | 1 h | Used to inhibit cell death induced by CMPF. The results showed that pretreatment with Ferrostatin-1 significantly reduced ROS production induced by CMPF | PMC9894909 |
HK-2 cells | 1 μM | 1 h | Used to inhibit cell death induced by CMPF. The results showed that pretreatment with Ferrostatin-1 significantly reduced ROS production induced by CMPF | PMC9894909 |
MCF-7 | 10 µM | 1 h | Fer-1 significantly attenuated IR-induced cell death in ER-positive MCF-7 and ZR-75-1, but not in ER-negative MDA-MB-231 cells | PMC8888677 |
BMSCs | 10 μM | 12 h | To evaluate the inhibitory effect of Ferrostatin-1 on bacteria-induced ferroptosis in BMSCs. Results showed that Fer-1 significantly reduced the mortality rate of BMSCs and decreased the accumulation of lipid peroxides and ferrous ions. | PMC11497072 |
LO2 cells | 10 μM | 24 h | Inhibited ferroptosis and alleviated CM-IH-induced lipid accumulation and ferroptosis phenotype | PMC11538716 |
HepG2 cells | 10 μM | 24 h | Inhibited ferroptosis and alleviated CM-IH-induced lipid accumulation and ferroptosis phenotype | PMC11538716 |
murine bone marrow-derived macrophages (BMDMs) | 10 µM | 4 days | inhibited Mtb-induced macrophage necrosis and lipid peroxidation | PMC6400546 |
A549 cells | 2 μM | 2 hours | To investigate the effect of iFSP1 on PAM-induced ferroptosis, results showed that iFSP1 enhanced PAM-induced ferroptosis. | PMC8901787 |
H1299 cells | 2 μM | 2 hours | To investigate the effect of iFSP1 on PAM-induced ferroptosis, results showed that iFSP1 enhanced PAM-induced ferroptosis. | PMC8901787 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
mice | DOX-induced cardiomyopathy model | subcutaneous injection | 1 mg/kg | daily for 7 days | significantly rescued DOX-induced cardiac dysfunction, fibrosis, and oxidative stress | PMC10400469 |
C57BL/6J mice | radiation-induced intestinal injury model | intraperitoneal injection | 5 mg/kg | once daily for 14 days | Fer-1 significantly improved the survival rate of mice and alleviated radiation-induced intestinal fibrosis | PMC10466894 |
Mice | Bone cancer pain model | Intraperitoneal injection | 10 mg/kg | Once daily for 20 consecutive days | FER-1 alleviated mechanical allodynia and thermal hyperalgesia in a mouse model of bone cancer pain and reduced spontaneous pain behavior. Furthermore, FER-1 inhibited the pain-associated activation of ERK1/2 and COX-2 expression and prevented the loss of GABAergic interneurons. | PMC10141498 |
mice | Doxorubicin-induced cardiotoxicity (DIC) model | intraperitoneal injection | 1 mg/kg | once daily for 2 weeks | To explore the influence of ferroptosis induced by DIC injury on E-Exe preconditioning, results showed that Fer-1 significantly alleviated DIC injury | PMC10878110 |
Rats | FTL knockdown pregnant rat model | Intraperitoneal injection | 2 μM/kg | Every two days until GD17.5 | Blocking ferroptosis significantly reversed the shFTL-induced PE-like phenotypes, including improvements in glomerular morphological damage, 24-hour proteinuria, and blood pressure. | PMC9706170 |
Balb/c mice | EC-induced liver injury model | Intraperitoneal injection | 1 mg/kg | 21 consecutive days | Fer-1 pretreatment significantly increased and liver index in mice, decreased serum AST and ALT levels, alleviated EC-induced liver inflammation and oxidative stress, and restored the protein expression of GPX4 and Ferritin. | PMC9142717 |
Mice | Pulmonary ZnONPs exposure model | Intraperitoneal injection | 10 mg/kg | Single dose, lasted for 3 days | Significantly reversed ZnONPs-induced vascular injury | PMC8726675 |
Mice | Acute osteomyelitis model | Intraperitoneal injection | 10 mg/kg | Once daily for 3 days | To evaluate the inhibitory effect of Ferrostatin-1 on bacteria-induced ferroptosis in BMSCs in vivo. Results showed that Fer-1 significantly reduced the levels of lipid peroxides in BMSCs. | PMC11497072 |
C57BL/6 mice | NAFLD model induced by high-fat diet and chronic intermittent hypoxia | Intraperitoneal injection | 1 mg/kg | Once daily for four weeks | Inhibited ferroptosis and alleviated HFD and CIH-induced liver function injury and lipid accumulation | PMC11538716 |
C57BL/6 mice | Mtb H37Rv infection model | Intraperitoneal injection | 3 mg/kg | Once daily from day 15 to day 28 post-infection | Reduced pulmonary necrosis and bacterial load | PMC6400546 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.81mL 0.76mL 0.38mL |
19.06mL 3.81mL 1.91mL |
38.12mL 7.62mL 3.81mL |
Tags: Ferrostatin-1 | Fer-1 | Ferrostatin 1 | ferroptosis | Fer 1 | antioxidant | ROS | neurotoxicity | inhibitor | 347174-05-4
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL